TEL REVELOL 40/25

AboutTel Revelol 40/25 combines Telmisartan, an angiotensin II receptor blocker (ARB), with Metoprolol, a selective beta-1 adrenergic blocker, to provide comprehensive treatment for hypertension. Telmisartan works by blocking the action of angiotensin II, a powerful vasoconstrictor, leading to relaxation of blood vessels and a reduction in blood pressure. Metoprolol complements this by reducing heart rate and the force of heart contractions, further lowering blood pressure and the heart's workload. This dual mechanism of action effectively controls high blood pressure, especially in patients who require more aggressive management or who have not responded adequately to monotherapy. The combination helps to reduce the risk of serious cardiovascular events such as stroke, heart attack, and kidney problems associated with uncontrolled hypertension, improving long-term cardiovascular health.UsesTreatment of essential hypertension.Management of high blood pressure not controlled by single agents.Reduction of cardiovascular risk in hypertensive patients.Long-term control of elevated blood pressure.Directions For UseTake this medication orally, usually once daily, with or without food, as directed by your doctor. Do not stop abruptly.BenefitsPotent and sustained blood pressure reduction.Dual action targeting different pathways of hypertension.Reduces risk of cardiovascular events.Convenient once-daily dosing.Well-tolerated in many patients.Provides comprehensive cardiovascular protection.Side EffectsDizzinessFatigueBradycardia (slow heart rate)HeadacheNauseaDiarrheaOrthostatic hypotensionCough (less common than with ACE inhibitors)Muscle painInsomniaCold extremitiesHyperkalemia (rare)Safety MeasuresAlcohol - Alcohol can increase the blood pressure-lowering effect and enhance side effects like dizziness and lightheadedness. Limit consumption.Pregnancy - Contraindicated during the second and third trimesters of pregnancy due to significant risk of fetal injury or death. Avoid in first trimester.Breastfeeding - Both components pass into breast milk. Not recommended during breastfeeding due to potential adverse effects on the infant.Liver - Use with caution in patients with severe hepatic impairment; dosage adjustments may be necessary. Monitor liver function.Kidney - Use with caution in patients with renal impairment; dosage adjustments are often required. Monitor kidney function, especially in severe cases.Lung - Use with caution in patients with asthma or severe COPD, as the beta-blocker component can worsen bronchospasm.DisclaimerMedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.Our goal is to complement, not replace, the essential doctor-patient relationship.